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ABSTRACT
Reduced sensitivity to naturally occurring and laboratory pain stimuli has been observed in individuals
with hypertension, high-normal blood pressure, and a family history of hypertension. The present study
sought to extend these findings by examining the relationship between familial history of hypertension
and pain responsivity in neonates. Eighty infants had intramuscular (lM) injections of vitamin K p€r-
formed in the delivery room within t h ofbirth as per institutional practice. Video recordings ofthe injec-
tion procedure were used by trained observers to code infant pain responses using facial grimacing and
cry duration. Prior to the birth ofthe child, the infants'parents each completed a family blood pressure
history survey and these responses were used to identifu infants with and without a maternal and pater-
nal family history of hypertension. As compared to infants without a maternal family history of hyperten-
sion, infants with a maternal family history of hypertension had significantly shorter crying times,(1,74)=6.96, p=.O'1, q2 =.086, and marginally lower facial grimacing scores, F(1,74)=2.68, p=.16,
42 =.O3s, during vitamin K injection. The presence of attenuated responses to the IM injection in neo-
nates with a maternal family history ofhypertension provides important and novel evidence that reduced
pain responding in individuals at risk for hypertension is not a learned response st5de, but rather may
arise from prenatal or genetic influences.
1. Introduction
Nearly three decades ofresearch has supported a link between
blood pressure and pain perception. Specifically, reduced sensitiv-
ity to a variet5r of naturally occurring and laboratory pain stimuli
has been observed in individuals with hypertension [16-18,22-
24,39 
-42,47,571, high-normal blood pressure {2,9,'17,27,29,33,46),
and a family history of hypertension. [1,5,10,11,13,30,33].
Although evidence of hypertensive hypoalgesia has also been ob-
tained in laboratory animal studies 128,35-37,48,50,52,561, an
important limitation inherent in human studies is the possibility
that the hyperrensive hypoalgesic effect reflects a decreased will-
ingness to report pain rather than a higher pain threshold. This no-
tion is supported in part by longstanding psychosomatic theories
and some empirical evidence associating hypertension and risk
for hypertension with affective blunting or inhibition of verbal
and motoric expression of negative emotional experience
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18,25,34,551. While it is difficult to refute this hypothesis due to
the inherently subjective nature of the pain experience, studies
that have compared nociceptive flexion reflex (NFR) thresholds in
offspring of hypertensive and normotensive parents provide an
important insight. The NFR is a polysynaptic spinal reflex that pro-
vides an objective index of individual differences in nociceptive
threshold. In the NFR paradigm, electrical stimulation is applied
to the surface of the foot to determine the minimum intensity re-
quired to activate small diameter (i.e., A-delta) nociceptive fibers
and a corresponding withdrawal response in the hamstring mus-
cles of the upper leg. Comparison of NFR thresholds in healthy
young adults with and without a parental history of hypertension
reveals higher thresholds in offspring of hypertensive parents
[14,i5,33], suggesting that greater nociceptive input is required
to elicit pain in those at increased risk for hypertension.
The present study provides an additional, unique test of the
relationship between risk for hypertension and pain perception
in neonates with and without a family history of hypertension.
As part of two separate investigations [45,491, parental family his-
tory of hypertension was obtained before labor and delivery. Neo-
natal pain responses were assessed during routine IM injection of
vitamin I( (to help prevent hemorrhagic disease of the newborn).
Because vitamin K injection is administered within an hour of
birth, the present approach provides a rare opportunity to examine
pain responses that are unlikely to be influenced by conditioning or
social learning. Based on the prior evidence of attenuated pain
responsivity in young adults at risk for hypertension, we hypothe-
sized that infants with a family history of hypertension would ex-
hibit a decreased pain responsivity as compared to infants without
a family history of hypertension.
2. Methods
2.1. Participants
Data for this study were obtained from a subset of patients re-
cruited as part of tvvo double-blind, placebo-controlled random-
ized trials (RCTs) conducted in the Labor and Delivery Unit of
Mount Sinai Hospital, Toronto, Canada [45,49]. In these studies,
neonatal pain responses were assessed during routine IM injection
of vitamin K. These studies were designed to test different inter-
ventions [sucrose 24% solution [49] and amethocaine a% gell45ll
to reduce newbom pain responses; however, when compared to
the placebo control, the treatments did not significantly influence
infant pain response to vitamin K injection. That is, neither drug
proved more effective than a placebo control condition in reducing
infant pain responses to vitamin K injection. Infants in these RCTs
were included in the present study if both parents completed a
survey describing their family history of hypertension.
2.2. Procedures
2.2.1. Family history of hypertension
The fathers and mothers of each infant were asked to complete
a personal blood pressure history survey [32] prior to the birth of
their child. Each parent completed a separate survey for their
own family history. The survey inquired about age, blood pressure
history (including typical blood pressure, prior diagnosis of hyper-
tension, and antihypertensive medication prescription), and his-
tory of hypertension in first-degree relatives. Although prior
studies on the relationship between pain and risk for hypertension
have typically compared pain ratings in those with and without a
parental history of hypertension (e.g., see France [1 1 ]), the present
study used an approach to assess family history effects that was
novel in two important respects. First, because ofthe very low inci-
dence of hypertension in these young parents, family history of
hypertension was determined on the basis ofthe infants'grandpar-
ents'blood pressure histories. Second, based on the evidence of
specific maternal prenatal and genetic influences on risk for hyper-
tension 17,26,541, we chose to consider the potential independent
contribution of both maternal and paternal family histories.
Specifically, infants were defined as having (1) a maternal fam-
ily history of hypertension if at least one of the mother's parents
was reported to have had a prior diagnosis of hypertension, (2) a
paternal family history of hypertension if at least one of the
father's parents was reported to have had a prior diagnosis of
hypertension, or (3) no family history of hypertension if neither
the maternal nor the paternal grandparents were reported to have
had a history of hypertension. It should be noted that paternal and
maternal grandparent blood pressure histories were based on the
surveys completed by the infants' father and mother, respectively,
and were not independently confirmed.
2.2.2. Vitqmin K injection
The IM injection of vitamin I( was performed in the delivery
room within t h ofbirth as per institutional practice. The neonates
were positioned supine on a resuscitation table. A digital video
camera (Sony DCR-TRV530 or DCR-TRV25, Sony Electronics Inc,
USA) was focused on the infant's face to record reactions to the
injection. Except for exposure ofthe leg that was used for the injec-
tion procedure, the infants were swaddled to prevent hand move-
ments obstructing the view of the face. A certified nurse or a
physician injected the infant with 0.5 ml of vitamin K (Sabex Inc,
Canada) using a 1 ml tuberculin syringe with a 25-gauge needle
(5/8'/ (16-mm) in depth) [19], The skin of the thigh was stretched
flat between the finger and the thumb and the needle was pushed
down at 90' angle through the skin. The injection technique was
based on the guidelines recommended by the World Health Orga-
nization [53]. The injection procedure included four phases: (1)
baseline, (2) cleaning the thigh, (3) injection, which included
inserting the needle into the thigh, aspirating to check whether a
vessel had been punctured and delivering the volume of injection,
and (4) recovery.
2.2.3. lnfant pain assessment
Neonatal facial grimacing and cry duration measures were
scored from the videotaped recordings ofthe vitamin K injection.
Percentage of facial grimacing was calculated on the basis of pres-
ence or absence of the three facial actions (brow bulge, eyes
squeeze and deepening ofthe naso-labial furrow) during 2-s inter-
vals for the first 20 s (or less if the phase lasted <20 s) of each pro-
cedure phase from the videotapes. The same coding procedure was
used for all phases. These three facial actions were chosen for the
study as they have been observed in 99% of neonates within 6 s
of an invasive procedure (heel lance), and are believed to be the
most sensitive indicators of infant pain [20]. The facial action data
were collapsed for each facial action into the percentage of time
the infant expressed the action (i.e., 0-100%), and an overall score
was computed by summing the percentage scores for the three fa-
cial actions and then dividing by three. The percentage oftime that
the infant cried during each phase was defined as the presence of
audible vocalizations associated with facial grimacing. [21,581.
The pain measures were scored by a single trained research assis-
tant (a different one for each RCT), who was not present during the
videotaping, blind to the study hypotheses, and unaware of the in-
fant's family history of hypertension. Data on the inter-rater reli-
ability were available for facial grimacing (lCC (r95% CI): 0.83
(0.76-0.93)) but not for cry duration.
This study was approved by the research ethics boards at Mount
Sinai Hospital and the Hospital For Sick Children and the Human
Participants Review Committee at York University. Parents of
potentially eligible neonates were identified and approached for
written consent and information conceming their family blood
pressure histories prior to their child's birth.
2.3. Stqtistical analysis
To examine the effect of family history of hypertension on in-
fant pain responses, a 2 (maternal family history of hypertension)
by 2 (paternal family history of hypertension) MANOVA was con-
ducted using difference scores (injection phase 
- 
baseline phase)
for both grimacing and crying time as the dependent variables.
Demographic and clinical variables were analyzed by one-way
ANOVA.
3. Results
Eighty parent couples returned completed family history of
hypertension forms that could be scored for the presence or ab-
sence of hypertension in the infants' parents and grandparents.
There were no significant differences between the infants with
and without a matemal or paternal family history of hypertension
Table 1
Mean (95% CI) for descriptive characteristics of infants with and without a maternal
family history of hypertension.
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in terms of birth weight, gestational age, matemal age or paternal
age. Descriptive characteristics of infants as a function of matemal
family history of hypertension are provided in Table 1. There were
42 infants with and 38 without a patemal family history of hyper-
tension, and 39 infants with and 41 without a matemal family his-
tory of hypertension.
Results of the MANOVA revealed a significant main effect of
maternal family history of hypertension, F(2,73) = 3.49, p < 0.05,
42 = .087, but no significant effect of patemal family history of
hypertension, F(2,73) = 0.91, p = O.40, 42 = .024. The interaction ef-
fect was also non-significant. As can be seen in Table 2, follow-up
ANOVAs of the maternal family history effect revealed significantly
shorter crying times, F(1,74) = 6.96, p = .O1,42 =.086, and margin-
ally lower facial grimacing scores, F(1,74) =2.68, p = ."lO, q2 = .035,
for offspring of mothers with a family history of hypertension ver-
sus those without a family history of hypertension. The maternal
history effect remained significant after controlling for the treat-
ment group to which the infants had been assigned in the original
RCTs (i.e., sucrose [49] or amethocaine [45] versus placebo) and did
not differ as a function of infant sex.
4. Discussion
The present study demonstrates a relationship between family
history of hypertension and decreased pain responsivity to an IM
injection in the newborn infants. Specifically, compared to infants
without a maternal family history of hypertension, neonates with a
matemal family history showed significantly smaller increases in
crying time and marginally smaller increases in facial actions in re-
sponse to the injection. These results provide novel evidence that
risk for hypertension may be associated with decreased pain not
as a result of social learning or environmental reinforcement, but
rather as a result of undetermined prenatal or genetic influences
in healthy infants with a maternal family history of hypertension.
Although this is the first study to examine hypoalgesia in in-
fants at increased genetic risk for hypertension, similar results
had previously been noted in animals. For example, spontaneously
hypertensive rats (SHRs), which have been selectively bred to de-
velop hypertension, demonstrate reduced responsiveness to noci-
ceptive stimuli as early as the third week of life [43,48].
Interestingly, exaggerated endogenous opiate activity has been
Table 2
Mean (95% CI) values for change (% during vitamin K injection minus % during pre-
injection baseline) in infant facial grimacing and crying time as a function ofmaternal
and paternal family history of hypertension.
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identified as a mediator of hypoalgesia in SHR, since administra-
tion of the opiate-receptor antagonist naloxone normalizes noci-
ceptive responding [648,52} Whereas elevated plasma opioid
levels have been reported in hypertensive humans 122,31,471,
opiate-receptor blockade studies havrc yielded mixed results.
McCubbin and colleagues [30] demonstrated that naltrexone re-
versed the reduced sensitivity to cold pressor pain in those with
high-normal blood pressure, and that-this effect was most pro-
nounced in those with high-normal blood pressure and a positive
family history of hypertension. In contrast, in other studies opi-
ate-receptor blockade has failed to significantly alter nociceptive
responding in individuals with hypertension [38,39], high-normal
blood pressure l29, al, or normotensive individuals with a family
history of hypertension [1 2].
The demonstration of decreased pain responsivity in infants
with a maternal family history of hypertension is perhaps most
important in that it provides evidence ofan early onset ofhypoal-
gesia; however, this finding is unique and interesting in at least
two additional respects. First, whereas prior studies have demon-
strated lower pain scores as a function of hypertension or a paren-
tal history of hypertension [1,5,10,11,13,30,33], this is the first
time that such an effect has been reported as a function of blood
pressure histories collected from grandparents. This suggests that
the effect of family history of hypertension on hypoalgesic
responding may be transmitted from one generation to the next,
and that inheritance effects may be best estimated on the basis
of a more extensive family history that goes beyond a single gen-
eration. Second, this is also the first study to examine hypoalgesic
responses independently for maternal and paternal family blood
pressure history. Accordingly, consistent with our finding that
hypoalgesia was associated exclusively with matemal transmis-
sion of risk for hypertension, it is possible that prior findings of re-
duced pain responsivitSr in offspring of hypertensives may have
been due primarily to maternal family history versus patemal fam-
ily history. This notion is consistent with the emerging evidence of
a maternal influence on the transmission of risk for hypertension
17,26,5411. Specifically, recent genetic studies demonstrate an
involvement of mitochondrial DNA mutations in the development
of hypertension in some families. Because mitochondrial DNA is
inherited exclusively from the mother, these studies suggest a
mode of inheritance of risk for hypertension that is based on a
matemal transmission pattern. Accordingly, the present findings
suggest that additional consideration of maternal inheritance
may provide important clues in the ongoing search for potential
mechanisms of hypertensive hypoalgesia in humans.
Although the present findings are intriguing, it must be noted
that there are limitations to the study and methods. First, this
was a pilot study including a subsample of infants, who were re-
cruited as a part of two separate randomized controlled trials. lt
is, therefore, advisable that the findings be reproduced on a larger
sample of infants. A larger sample size may also help address a sec-
ond limitation, which relates to the fact that we observed signifi-
cant group differences in infant cry times but only marginal
differences in facial grimacing. Significant differences on both vari-
ables may be obtained with larger samples; however, the observed
effect sizes were small, and this may be related to the challenge
inherent in accurately identifying infant risk for hypertension on
the basis of familial history reports. Specifically, an important lim-
itation in all studies that use family history as a marker of hyper-
tensive risk is the potential for both false-positive and false-
negative group assignments. False positives occur when those
identified as at high risk based on family history do not go on to
develop the disorder, whereas false negatives occur when those
identified as at low risk based on familial history go on to develop
hypertension. Because these problems occur at varying and
unknown rates, the error variance associated with risk group
6X.AV8n-?A;Q)
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assignment is likely inflated. A third and potentially related limita-
tion is that mothers in the present sample were approximately fwo
years younger than the fathers. Although this is a small age differ-
ence, this could increase false negatives in the maternal family his-
tory (i.e., the maternal grandparents may be younger and,
therefore, may be less likely to have developed hypertension)
and reduce false positives in the maternal family history as a youn-
ger diagnosis of hypertension is associated with a higher risk for
the disorder in the next generation [51]. A fourth limitation is that
in the present study, parental reports of hypertension in them-
selves or their family were not confirmed; given that prior studies
have only considered a parental history of hypertension, it would
be beneficial to conduct more extensive pedigree charts to provide
comprehensive assessment of family history of hypertension. Fi-
nally, the absence of specific data on inter-rater reliably for cry
duration is a limitation, although coders were trained and partici-
pated in inter-rater reliability testing prior to the study. Notwith-
standing these caveats, from a practical perspective hypoalgesia
may serve as a valuable method of identiffing those at greatest risk
for hypertension among otherwise heterogeneous groups of off-
spring of hypertensives. Consistent with this notion, Campbell
and colleagues [3,4] followed a sample of young males from ado-
lescence until early adulthood and reported that early hypoalgesia
was a significant predictor ofblood pressure up to eight years later,
even after controlling for parental history of hypertension and ini-
tial resting blood pressure levels. Although longer follow-up studies
are needed to examine the potential unique and interactive rela-
tionship between hypoalgesia and family history in the prediction
of actual hypertension, hypoalgesia appears to add additional vari-
ance to the prediction offuture blood pressure, and thus may serve
as a behavioral marker of hypertensive risk that could be used to
promote early and efficient identification of strong candidates for
pharmacological and non-pharmacological prevention efforts.
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